Anti-Osteocalcin antibody
4
(5 Reviews)
|
(22 Publications)
Rabbit Polyclonal Osteocalcin antibody. Suitable for IHC-P and reacts with Human samples. Cited in 22 publications. Immunogen corresponding to Synthetic Peptide within Human BGLAP.
View Alternative Names
Osteocalcin, Bone Gla protein, Gamma-carboxyglutamic acid-containing protein, BGP, BGLAP
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Osteocalcin antibody (AB198228)
Immunohistochemical analysis of paraffin-embedded Human ovarian cancer tissue labeling Osteocalcin with ab198228 at 1/60 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Osteocalcin antibody (AB198228)
Immunohistochemical analysis of paraffin-embedded Human breast cancer tissue labeling Osteocalcin with ab198228 at 1/60 dilution.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Osteocalcin plays a significant role in regulating glucose metabolism and fat deposition. It acts as a hormone from the bone and influences energy metabolism and insulin sensitivity. Osteocalcin undergoes carboxylation a post-translational modification necessary for its function in bone. Beyond its structural role demineralized osteocalcin has been found to impact pancreatic β-cell function adipose tissue and male fertility although the pathways in these processes are not entirely understood yet.
Pathways
Osteocalcin is associated with the energy metabolism and bone remodeling pathways. It interacts with the insulin signaling pathway influencing insulin secretion by pancreatic β-cells and boosting insulin sensitivity. This interaction involves proteins like insulin receptor substrate 1 (IRS1) and glucose transporter type 4 (GLUT4) which play roles in glucose uptake. Osteocalcin also connects to bone remodeling pathways by influencing osteoclast differentiation and activity through osteoprotegrin and receptor activator of nuclear factor kappa-B ligand (RANKL).
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
Journal of functional biomaterials 16: PubMed40137373
2025
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 9: PubMed39405183
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 15:227 PubMed39075596
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of medical sciences 21:137-150 PubMed38164350
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cells 12: PubMed37830549
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature 621:602-609 PubMed37704733
2023
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:6834-6847 PubMed37462732
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37240030
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:210 PubMed36639727
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 13: PubMed36671506
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com